SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

AFJK is generating intense community conversation, characterized by extremely high volatility and speculative trading, as it continues to exhibit patterns seen in other low-float, China-linked stocks that have recently experienced dramatic price movements. Many traders are chasing potential explosive gains, while others caution about the stock's "pump and dump" reputation and the significant risks of rapid reversals and trading halts.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending amid a sharp stock price decline to 52-week lows, sparking intense debate among investors. Bulls emphasize strong fundamentals like a $1.4 billion contract and robust financials, while attributing the suppressed price to alleged manipulation and purchasing restrictions by major brokerage firms, fueling expectations of a future squeeze. Skeptics, however, point to management's communication issues and past perceived misleading announcements, questioning the company's ability to translate business growth into shareholder value.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is trending amid a broader 'SPAC mania,' with traders highlighting its extremely low float as a key catalyst for potential explosive price action. The community is actively comparing ESHA to recent low-float SPAC runners like AFJK and ASPC, anticipating a significant sympathy play or short squeeze. This has generated intense speculative interest, despite some underlying skepticism, as many expect ESHA to follow its peers with parabolic gains.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending, fueled by an exceptionally active and dedicated community passionately championing the "OG meme" narrative of Rage Comics. This committed base is consistently building out an ecosystem with tools like RageMaker and RageGames, aiming to onboard new users into crypto, while expressing strong conviction for significant long-term growth and widespread recognition within the market.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending following its recent FDA approval of NEREUS (tradipitant), marking the first new motion sickness drug in nearly 40 years. The community is buzzing with excitement over its significant potential to address GLP-1 induced nausea and vomiting, fueling widespread speculation about a potential buyout by major pharma and a substantial re-rating of the stock's valuation. Investors are largely bullish, anticipating further upside driven by this approval and additional pipeline catalysts.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is actively discussed after China officially extended EV trade-in subsidies into 2026, offering significant incentives for new energy vehicle purchases. This policy tailwind, combined with strong delivery growth for its ES8 model and continuous expansion of its battery swap network, is fueling community optimism about the company's path to profitability, while also driving conversations around perceived market manipulation.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

The iShares Silver Trust ($SLV) is experiencing extreme volatility due to the CME's recent margin hikes and impending Chinese export restrictions on silver, fueling intense market speculation. Bulls are aggressively anticipating a significant short squeeze, citing growing industrial demand from sectors like AI and a decoupling of physical versus paper market prices. Conversely, bears warn of an orchestrated pump-and-dump, predicting sharp corrections as leveraged positions face potential liquidation.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co

Alpha Capital Acquisition Co. (ASPC) is trending with intense speculative interest, driven by community comparisons to recent low-float "Chinese SPAC" stocks that have experienced significant price volatility. Discussion is highly polarized between those anticipating a massive short squeeze due to high borrow rates and others warning of a potential pump-and-dump scenario. This dual narrative of extreme bullishness and caution, fueled by historical patterns of similar tickers, is generating considerable buzz.

Ekso Bionics Holdings, Inc. engages in the provision of design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.

Ekso Bionics Holdings Inc

Ekso Bionics Holdings is trending due to its proposed business combination with Applied Digital Cloud to form ChronoScale Corporation, an entity focused on AI-accelerated computing infrastructure. This catalyst has sparked intense community discussion, with many anticipating significant upside from the AI sector and low float dynamics, while a strong counter-narrative raises concerns about potential shareholder dilution and the merger's unfavorable terms for existing EKSO holders.

Themes ETF Trust - Leverage Shares 2X Long UNH Daily ETF

Leverage Shares 2X Long UNH Daily ETF

The Leverage Shares 2X Long UNH Daily ETF (UNHG) is facing significant community backlash following an unexpected dividend event that caused a sharp decline in its value, despite the underlying UNH stock remaining relatively stable. Investors are expressing widespread confusion and frustration, with many labeling the event as "scam," "decay," or "manipulation," leading to intense debate over the legitimacy and operational transparency of this new leveraged ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of +8.64% and +2.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Lags Revenue Estimates

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements. It operates through the Diagnostic Services and Consumer Products segment. The Diagnostic Services segment includes COVID-19 and other diagnostic testing services. The Consumer Products segment consists of the manufacturing, retail customers, and personal genomics products and services. The company was founded by Guy J. Quigley and Charles A. Phillips in July 1989 and is headquartered in Garden City, NY.

Current Price	$0.4533
Prev Close	$0.45
Open	$0.4312
Dividend Yield	0.00%
50-Day Moving Average	$2.22
Beta	1.43
Avg. Volume	130,081.16
PE Ratio	-0.03

52-Week High	$9.35
52-Week Low	$0.4116
Market Capitalization	$6.62M
EPS (Annual)	-$26.08
Price to Book	0.27
Revenue Per Employee	$70,520.83
Enterprise Value/EBITDA	N/A

PRPH
ProPhase Labs Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PRPH News

PRPHProPhase Labs Inc